Evelo Biosciences

$4.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.17 (-3.55%) Today
$0.00 (0.00%) As of 8:00 AM EDT after-hours

Why Robinhood?

You can buy or sell EVLO and other stocks, options, and ETFs commission-free!

About EVLO

Evelo Biosciences, Inc. operates as a clinical stage biotechnology company. The firm engages in the development of monoclonal microbials, a modality of oral biologic medicines. Read More It has three product candidates, EDP1066 and EDP1815 for the treatment of inflammatory diseases and EDP1503 for the treatment of cancer. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA. The listed name for EVLO is Evelo Biosciences, Inc. Common Stock.

Employees
98
Headquarters
Cambridge, Massachusetts
Founded
2014
Market Cap
213.15M
Price-Earnings Ratio
Dividend Yield
Average Volume
196.79K
High Today
$4.90
Low Today
$4.55
Open Price
$4.87
Volume
121.21K
52 Week High
$8.30
52 Week Low
$3.01

Collections

EVLO Earnings

-$0.78
-$0.52
-$0.26
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 3, Pre-Market

You May Also Like